Healix (503B Compounding Pharmacy Services Division) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 1
Healix (503B Compounding Pharmacy Services Division) General Information
Description
Provider of compounded sterile preparation services. The company provides high-quality, ready-to-use compounded sterile preparations to hospitals across the country through its manufacturing facility that is registered with the U.S. Food and Drug Administration (FDA) as an Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Contact Information
- 14140 Southwest Freeway
- Suite 400
- Sugar Land, TX 77478
- United States
Healix (503B Compounding Pharmacy Services Division) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Healix (503B Compounding Pharmacy Services Division)‘s full profile, request access.
Request a free trialHealix (503B Compounding Pharmacy Services Division) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Healix (503B Compounding Pharmacy Services Division)‘s full profile, request access.
Request a free trial